David Fuglsang-Damgaard

David Fuglsang-Damgaard is a Chief Physician and Researcher at the Department of Clinical Microbiology, Aalborg University Hospital, affiliated with the Faculty of Medicine at Aalborg University. His work focuses on infectious diseases, genomic epidemiology, and medical microbiology, with particular emphasis on bacterial pathogens like Streptococcus pyogenes and viral variants such as SARS-CoV-2. He contributes to public health surveillance and diagnostic method development.

Research Interests: His studies span the molecular epidemiology of bacterial and viral pathogens, including lineage tracking of SARS-CoV-2 variants and the emergence of antibiotic-resistant strains. He explores diagnostic techniques like RT-qPCR for variant identification and investigates the transmission dynamics of pathogens in populations.

Publications Trends: Recent work highlights the rise of invasive group A streptococcal infections, Omicron variant differentiation, and transmissibility of SARS-CoV-2 Alpha variant. His research bridges clinical diagnostics, genomic analysis, and public health response strategies.

Press/Media: Featured in news outlets for his expertise on coronavirus testing and pandemic responses. His work has been cited in policy documents and widely shared on social media.

Labs/Teams: Active in the Danish COVID-19 Genome Consortium, collaborating on genomic surveillance and outbreak analysis. His team contributes to national and international efforts to combat infectious diseases.